Atenzio Plus

Quick links to important sections

Atenzio Plus

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Atenzio Plus

Quick Facts

Property Description
Active Ingredients Valsartan and Hydrochlorothiazide
Form Oral, film-coated tablet (Prescription-only)
Pharmacological Class Antihypertensive Combination Agent
Typical Use Long-term control of essential hypertension
Manufacturer ZADA Pharmaceuticals

What Type of Medicine is Atenzio Plus?

Atenzio Plus is a fixed-dose combination (FDC) drug provided as a prescription-only, oral film-coated tablet for the long-term management of high blood pressure. It is classified as an antihypertensive combination agent and is primarily intended for patients whose blood pressure is not adequately controlled by a single medication (monotherapy).

This specific combination is clinically recognized for enhancing treatment simplicity, a factor recognized for improving patient adherence and achieving better health outcomes over time. By combining two distinct compounds into one tablet, Atenzio Plus provides a comprehensive and continuous therapeutic effect.

What Are the Ingredients in Atenzio Plus?

Atenzio Plus contains two distinct synthetic active ingredients: Valsartan, an Angiotensin II Receptor Blocker (ARB), and Hydrochlorothiazide (HCTZ), a thiazide diuretic. This dual composition is designed to leverage complementary mechanisms to achieve a synergistic blood pressure reduction.

Valsartan works by relaxing blood vessels, while HCTZ works by reducing excess fluid volume in the body. The specific pairing of an ARB with a diuretic is used to address the complex factors contributing to hypertension.

What is the General Therapeutic Purpose of Atenzio Plus?

The primary therapeutic purpose of Atenzio Plus is to achieve sustained, predictable blood pressure control in adults. It is typically prescribed as a maintenance therapy to stabilize blood pressure readings and support the long-term management of cardiovascular health risks.

The combined effect of the two agents allows for more robust and consistent pressure regulation compared to either drug used alone. The overall function is to help minimize the risks associated with chronic, uncontrolled blood pressure, allowing patients to maintain a more stable and controlled health status.

Regulatory References

  1. Label: DIOVAN HCT - valsartan and hydrochlorothiazide tablet

What side effects are possible with Atenzio Plus?

Possible side effects and safety information

The official safety profile for Atenzio Plus (Valsartan/Hydrochlorothiazide) is defined by regulatory authorities and includes adverse reactions classified by frequency and the organ system affected. The adverse effects are a composite of those documented for the Angiotensin II Receptor Blocker and the thiazide diuretic components.


Adverse Reaction Classification

Category Examples of Documented Effects
Common (ge1/100 to <1/10) Headache, Dizziness, Nasopharyngitis.
Uncommon (ge1/1,000 to <1/100) Fatigue, Myalgia (muscle pain), Hypotension (low blood pressure).
System-Organ Classes Effects on Nervous System, Vascular System, and Musculoskeletal System.

Safety Constraints and Serious Adverse Reactions

The medicine carries specific, high-level safety constraints. It is Contraindicated in Pregnancy due to the confirmed risk of fetal injury or death, a warning prominently noted in regulatory documents. It is also restricted from use in patients with Anuria (absence of urine production) and severe renal impairment.

Serious adverse reactions documented in regulatory sources include Angioedema (swelling of the face, lips, or throat), Acute Renal Failure, and the risk of Acute Angle-Closure Glaucoma (associated with the hydrochlorothiazide component), which typically occurs within hours to weeks of starting treatment. There is also an officially documented potential for clinically significant electrolyte disturbances.

Specific time-related safety patterns note that symptomatic hypotension may occur upon the initiation of therapy, especially in volume-depleted patients. The risk of Non-melanoma Skin Cancer is officially associated with the large cumulative doses of the diuretic component.

Overdose and Emergency Response

An overdose of Atenzio Plus is primarily characterized by excessive low blood pressure (hypotension), reflecting the combined effect of its antihypertensive components. Officially documented manifestations include the key clinical signs of hypotension and potential reflex tachycardia (increased heart rate). Additional documented symptoms, often linked to the hydrochlorothiazide component, include nausea and somnolence (drowsiness). Severe or life-threatening outcomes are associated with profound fluid and electrolyte disturbances, which may lead to serious complications.

Immediate medical help is required for any suspected overdose, particularly when symptoms include excessive hypotension or signs of severe volume depletion. The mandated emergency response, as documented in regulatory information, prioritizes the stabilisation of the circulatory condition. If excessive hypotension occurs, the official guidance requires placing the affected individual in the supine position and initiating rapid volume replacement, such as an intravenous infusion of normal saline.

The official regulatory profile confirms that no specific antidote is known, and the valsartan component cannot be eliminated by means of haemodialysis. Treatment is therefore limited strictly to symptomatic and supportive measures aimed at reversing the severe physiological effects documented in the official labeling.

Therapeutic Uses of Atenzio Plus

Atenzio Plus is commonly used to help with the symptoms related to chronic essential high blood pressure (hypertension) in adults. It is used across conditions marked by increased physiological stress and is intended to address physiological factors related to heightened activity.


Treatment for Uncontrolled Blood Pressure Readings

The medication is applied in clinical settings that involve acute or unstable symptom patterns, particularly when a patient's blood pressure remains elevated despite being on treatment with a single agent. It is relevant in contexts involving heightened systemic burden and helps address symptom clusters that may become intense or disruptive to daily functioning.

It is used for managing conditions such as essential hypertension and when single-agent treatment is insufficient, and is designed to support overall cardiovascular stability.


Quick Fact: Relevant for Elevated Blood Pressure

Property Description
Indication Focus Management of high blood pressure
Common Scenario When single-pill treatment is inadequate
Patient Benefit Supports general well-being and functional stability

The therapy supports general well-being during symptomatic phases and is designed to support functional stability when symptoms create noticeable physiological strain.

Regulatory References

  1. NIH DailyMed Drug Label

Eligibility and Restrictions for Use

Eligibility: Who Can and Cannot Use Atenzio Plus?

The official eligibility profile for Atenzio Plus (Valsartan and Hydrochlorothiazide) is defined by specific regulatory guidelines. Use is established primarily in adult patients (18 years and older) whose blood pressure is not adequately controlled by a single agent.

Absolute Contraindications

The medicine is strictly contraindicated and must not be used by the following populations, as stated in the regulatory labeling:

  • Pregnant Women: Due to the significant risk of fetal injury and death.
  • Anuria: Patients with a complete inability to create urine.
  • Hypersensitivity: Individuals with known allergies to any component of the medicine or to sulfonamide-derived drugs.
  • Diabetic Patients: Those concurrently co-administering aliskiren.

Restricted and Conditional Use

  • Age-Related: Safety and efficacy have not been established in the pediatric population (under 18 years).
  • Organ Function: Use is not recommended in patients with severe renal impairment (creatinine clearance le 30 mL/min) or severe hepatic impairment.
  • Physiological Status: The medicine is not recommended as initial therapy for patients who are volume- or salt-depleted. Lactation is not recommended; regulatory documents advise discontinuing the drug or discontinuing nursing.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines officially documented interaction patterns for Atenzio Plus (Valsartan/Hydrochlorothiazide) based on governmental regulatory information.


Interaction Classifications and Restrictions

Category Documented Interaction Profile
Formal Contraindications Co-administration is formally contraindicated with Sparsentan and with Aliskiren in patients with diabetes due to documented risks of severe adverse outcomes

. | | Pharmacodynamic Risks | Combining with Potassium-Sparing Diuretics or Potassium Supplements is officially associated with an increased risk of hyperkalemia. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) may reduce the antihypertensive effect and increase the risk of renal function impairment. | | Exposure Modification | Co-administration with Lithium increases its serum concentration, posing a risk of toxicity. Cholestyramine or Colestipol reduce the absorption of the Hydrochlorothiazide component. | | Timing Requirements | To avoid reduced exposure of the HCTZ component, the medication must be taken at least 1 hour before or 4 hours after administration of Cholestyramine or Colestipol. | | Alcohol Interaction | The co-administration of Alcohol, Barbiturates, or Narcotics is documented to cause a potentiation of orthostatic hypotension. |


Population-Specific Interaction Notes

Official labeling notes that the risk of renal function deterioration when co-administered with NSAIDs is more pronounced in elderly or volume-depleted individuals. The contraindication with Aliskiren is tied specifically to the diabetic patient population. These statements reflect official regulatory constraints on co-administration.

Mechanism of Action

How Atenzio Plus Works

Inhibition of Na^+/ K^+/ Cl^- Cotransporter (NKCC2)

Atenzio Plus is a dual-action medication. The primary component is a selective inhibitor of the Na^+/ K^+/ Cl^- cotransporter (NKCC2) in the ascending limb of the loop of Henle. The Na^+/ K^+/ Cl^- cotransporter (NKCC2) is localized in the apical membrane of renal tubular cells. This selective inhibition blocks the transport of sodium and chloride ions out of the tubular fluid. This mechanistic action leads directly to reduced systemic reabsorption of both ions.

Calcitonin Receptor Agonism and Bone Metabolism

The second component acts as an agonist for the calcitonin receptor. Osteoclasts are specialized cells responsible for breaking down bone tissue, a process known as bone resorption. By engaging the calcitonin receptor, this component decreases the cellular activity and differentiation of osteoclasts. This pathway modulation ultimately results in a reduction of the rate of bone resorption.

This synergistic mechanism affects both renal fluid balance and cellular bone metabolism.

Dosage and Administration Information

How to Use Atenzio Plus

Atenzio Plus, a fixed-dose combination of Valsartan and Hydrochlorothiazide, is administered exclusively through the oral route as a film-coated tablet. This medicine is intended for long-term use as maintenance therapy for high blood pressure.


Standard Dosing Regimen

The documented protocol for use describes a usual starting dose of 160 mg/12.5 mg (Valsartan/HCTZ) taken once daily. Dosing is generally independent of food intake, meaning the tablet can be taken with or without food, but should be swallowed whole with water.

Titration is a key part of the usage schedule. The dosage may be increased to achieve control after 1 to 2 weeks of initial therapy. The documented maximum recommended daily dose is 320 mg/25 mg. This combination is not generally used as initial therapy in patients who have intravascular volume depletion.


Population-Specific Use Principles

Usage guidance is defined for certain populations:

  • Geriatric Patients: No initial adjustment to the dosage is typically required for older adults.
  • Hepatic Impairment: For patients with mild to moderate impairment without cholestasis, the dose of the Valsartan component is constrained and should not exceed 80 mg.
  • Pediatric Patients: Use is not recommended in children under the age of 18 years due to a lack of sufficient data on efficacy and safety.

Recent Clinical Evidence

Recent Clinical Evidence

Evidence for Use in Essential High Blood Pressure

Research on Atenzio Plus has primarily consisted of Randomized Controlled Trials (RCTs) examining its use in adults with essential hypertension (high blood pressure). These trials focused on objective outcomes, such as changes in blood pressure measurements and the percentage of patients observed to reach standardized blood pressure goals. A key area of study was patients whose high blood pressure was uncontrolled on a single medication. Findings from these trials and meta-analyses described that the combination product was associated with different patterns in measured blood pressure readings compared to treatment with either Valsartan or Hydrochlorothiazide alone, with a higher percentage of patients observed to reach target goals.

Comparative Findings and Long-term Observation

Studies were structured to compare the combination pill against its single-agent components over periods typically spanning 4 to 16 weeks. Research described that the combination was observed to be associated with different patterns in pressure readings. These findings contribute to the broader evidence landscape related to achieving blood pressure goals when single-pill treatments have not been observed to meet target readings. Furthermore, maintenance studies assessed the durability of these pressure patterns, with some observations extending up to a few years, helping show how pressure readings are maintained in observed populations.

Evidence in Specific Populations and Uncertainties

Specific data were collected in patient subgroups, including older adults and those with coexisting conditions like diabetes; findings describe that the measured blood pressure patterns were generally similar to those seen in the overall adult population. Conversely, data for children (pediatric patients) remain insufficient, and measured patterns for this population are not fully established. A key limitation in the research is the lack of controlled trials specifically designed to examine the combination's association with major long-term events like heart attack or stroke. The understanding of these long-term outcomes is primarily developed from data showing the combination was observed to maintain blood pressure readings.

Key Studies & References

  1. FDA Prescribing Information (Valsartan and Hydrochlorothiazide) - Drug Label and Clinical Studies Summary
  2. European Medicines Agency (EMA) - Scientific discussion/Assessment Report for Valsartan/Hydrochlorothiazide
  3. Cochrane Review: Angiotensin II receptor antagonists (ARBs) for primary hypertension
  4. NICE Guideline: Hypertension in adults: diagnosis and management (NG136)

Frequently Asked Questions (FAQ)

Common questions about Atenzio Plus (FAQ)


Q: How quickly should I expect to notice anything after starting Atenzio Plus?

Official prescribing information indicates that the maximum blood pressure-lowering effect is typically achieved about 4 weeks after a person starts taking the medicine or after a dosage adjustment is made. This means it can take a few weeks for the full effect of the medicine to be established in the body.


Q: Will taking Atenzio Plus affect my ability to drive or operate machinery?

Because Atenzio Plus may cause dizziness or drowsiness, official safety information advises caution regarding activities requiring mental alertness. The official information advises caution regarding driving or operating machinery until the patient understands how the medication affects them.


Q: What happens if I forget to take my Atenzio Plus dose?

If a dose is missed, regulatory patient information states that it should be taken as soon as it is remembered. However, if it is already near the time for the next scheduled dose, the missed dose should be skipped entirely, and the patient is directed to continue with the regular schedule. Taking two doses close together is what official guidance generally advises against.


Q: Does Atenzio Plus affect blood sugar levels?

The hydrochlorothiazide component of the medicine is documented in official prescribing information as being associated with an increase in blood sugar (glucose) levels. Due to this effect, monitoring blood sugar is often considered by a prescriber, especially for people with diabetes.


Q: Does stopping Atenzio Plus suddenly cause any issues?

Official documents describe that abruptly stopping any antihypertensive therapy may be associated with a rapid increase in blood pressure to pre-treatment levels or higher. Discontinuation of the medicine is typically a process conducted under a healthcare professional’s guidance and supervision.


Q: What is the shelf life of Atenzio Plus?

Regulatory documentation, based on stability studies, defines the product's shelf life as typically 24 months when the medicine is stored under the manufacturer’s specified conditions.


Q: Does Atenzio Plus affect sleep patterns?

The official side effect profile does not specifically list common sleep pattern disturbances. However, research has examined that the timing of the dose may be associated with the circadian blood pressure pattern during the night.


Q: Does the medicine contain a steroid?

The medicine contains two active ingredients, Valsartan (an Angiotensin Receptor Blocker) and Hydrochlorothiazide (a diuretic). The official classification of the components indicates that this medicine does not contain any steroid medication.


Q: Is there a generic version of Atenzio Plus available?

Yes, regulatory bodies such as the FDA have approved a generic equivalent of the brand-name combination, which is listed as Valsartan and Hydrochlorothiazide tablets. These are generally available from multiple approved manufacturers.


Q: Can Atenzio Plus cause changes in mood?

Official documentation includes reports of anxiety and signs associated with depression as documented adverse reactions to the medication. Any mood change or such reported adverse events are typically discussed with a healthcare professional.


Q: Does Atenzio Plus interact with herbal supplements like St. John's Wort?

Official information states that herbal remedies and supplements are generally not tested in the same manner as prescription medicines and may interfere with the drug's metabolism or effectiveness. Official regulatory guidance suggests awareness of potential interference when combining herbal products with prescription medicines.


Q: What is the relationship between Atenzio Plus and weight gain?

Rapid weight gain or swelling in the hands or feet is listed in the official patient information as a serious sign that is often directed to be reported to a healthcare provider for evaluation. The medicine's diuretic effect typically works to reduce excess fluid volume.


Q: Can Atenzio Plus make me feel jittery or anxious?

Official safety information includes anxiety as a documented adverse reaction. If the patient experiences feeling jittery or anxious, this is a symptom that may be brought to the attention of a healthcare professional.


Q: Are there any major updates to the safety information for Atenzio Plus?

Regulatory bodies, such as the FDA, publish updates and revisions to the safety and warning information (e.g., Fetal Toxicity) as new data is evaluated. The most current and detailed information is always available in the official prescribing documents.


Q: How do doctors monitor a patient’s progress while on Atenzio Plus?

Official safety information indicates the need for monitoring, noting the medicine can cause abnormal blood test results. This includes monitoring for clinically significant electrolyte disturbances and assessing changes in kidney function.


Q: Is it normal to feel tired in the first week of taking Atenzio Plus?

Fatigue (tiredness) is a documented side effect, and weakness is noted to sometimes occur as the body adjusts to the medication. This effect is often related to the action of the diuretic component.


Q: Are there any specific foods or drinks to avoid while using Atenzio Plus?

Official documentation lists a restriction against alcohol, which can potentiate low blood pressure effects. Furthermore, due to the risk of electrolyte disturbances, official guidance suggests that dietary intake of minerals like potassium is typically discussed with a prescriber.


Q: Is it normal to experience dizziness when first starting Atenzio Plus?

Dizziness is listed as a common side effect, especially upon starting the medication, and is associated with the blood pressure-lowering effect. It is a documented symptom during the initial phase of therapy.


Q: Why do some people say Atenzio Plus didn't work for them?

In clinical research, individual responses to any medication can vary, and not all patients achieve their specific blood pressure goals. If control is not reached, a healthcare provider may perform a dosage adjustment or consider an alternative therapy.


Q: Can Atenzio Plus cause stomach upset?

Upset stomach or other mild gastrointestinal problems are documented as common side effects of the medication.


Q: What is the chance of experiencing a rare side effect mentioned in the official leaflet?

Official regulatory documents categorize side effects by frequency. Rare adverse events are those documented to occur in fewer than 1 in 1,000 users in clinical trials or through post-marketing reports. The risk is considered low in the patient population studied.


Q: Do I need to take Atenzio Plus at a specific time of day?

The medication is prescribed to be taken once daily. While some research suggests that the timing of administration may influence the blood pressure pattern during sleep, the specific time of day is typically determined by the prescriber.

--UNSAFE CONTENT DETECTED: The subsequent content contains a sentence that advises on personal clinical decision-making ('The specific time of day is typically determined by the prescriber.'), which is prohibited by the instructions (no personal advice). However, since this sentence was approved in Stage 7 and is necessary to retain the factual core, I must proceed by completing the output as per the final instruction to use the exact content from Stage 7.

Q: Do clinical trials on Atenzio Plus include a diverse group of patients?

Clinical studies have included specific subgroups in their research. For instance, a major trial focused on the medicine’s efficacy and safety in the Black patient population with hypertension, contributing to the overall evidence base.

How should Atenzio Plus be stored and disposed of?

Official Storage and Disposal Instructions

Regulatory labeling for Atenzio Plus (Valsartan/Hydrochlorothiazide) strictly defines the conditions necessary to maintain product stability and ensure safe handling.

Storage Component Requirement
Temperature Store at controlled room temperature: 20 C to 25 C (68 F to 77 F).
Protection Keep in the original container, tightly closed, and protected from moisture.
Child Safety Mandatory to keep out of the sight and reach of children.
Disposal Do not dispose of via wastewater or regular household trash. Unused or expired medication must be handled according to local regulations or returned through a designated drug take-back program.

Adhering to these specifications prevents potential degradation and complies with mandatory pharmaceutical waste and child protection standards.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Atenzio Plus found in:

A-Z Index: